321 related articles for article (PubMed ID: 17564318)
1. Pharmacokinetics, blood partition, and tissue distribution of itraconazole.
Lee JH; Shin JH; Lee MG
Res Commun Mol Pathol Pharmacol; 2004; 115-116():203-15. PubMed ID: 17564318
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, blood partition and protein binding of DA-7867, a new oxazolidinone.
Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2004 Apr; 25(3):127-35. PubMed ID: 15083501
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, stability, and blood partition of 7-anilino-5,8-isoquinolinedione, a new isoquinonlinedione derivative.
Kim SH; Moon YJ; Ryu CK; Lee MG
Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):419-29. PubMed ID: 11589368
[TBL] [Abstract][Full Text] [Related]
4. Stability, blood partition, and pharmacokinetics of a new proton pump inhibitor, YJA-20379-8.
Chung SY; Han KS; Chung YK; Chang MS; Lee MG
Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):187-200. PubMed ID: 9667073
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation.
Mouton JW; van Peer A; de Beule K; Van Vliet A; Donnelly JP; Soons PA
Antimicrob Agents Chemother; 2006 Dec; 50(12):4096-102. PubMed ID: 16982783
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, stability, and blood partition of DA-8159, a new phosphodiesterase V inhibitor.
Shim HJ; Lee EJ; Kim SH; Kim SH; Yoo M; Kwon JW; Kim WB; Lee HS; Lee MG
Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):275-86. PubMed ID: 11913718
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients.
Mohr JF; Finkel KW; Rex JH; Rodriguez JR; Leitz GJ; Ostrosky-Zeichner L
Antimicrob Agents Chemother; 2004 Aug; 48(8):3151-3. PubMed ID: 15273137
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
Yoon WH; Park SJ; Kim IC; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic interaction of ketoconazole and itraconazole with ciprofloxacin.
Abou-Auda HS; Mustafa AA; Al-Humayyd MS
Biopharm Drug Dispos; 2008 Jan; 29(1):29-35. PubMed ID: 17943700
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole disposition after single oral and intravenous and multiple oral dosing in healthy cats.
Boothe DM; Herring I; Calvin J; Way N; Dvorak J
Am J Vet Res; 1997 Aug; 58(8):872-7. PubMed ID: 9256973
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intravascular itraconazole in the American horseshoe crab (Limulus polyphemus).
Allender MC; Schumacher J; Milam J; George R; Cox S; Martín-Jiménez T
J Vet Pharmacol Ther; 2008 Feb; 31(1):83-6. PubMed ID: 18177324
[No Abstract] [Full Text] [Related]
12. Stability, tissue metabolism, tissue distribution, and blood partition of DA-1131, a new carbapenem.
Kim SH; Kim WB; Lee MG
Res Commun Mol Pathol Pharmacol; 1995 Dec; 90(3):347-62. PubMed ID: 8746482
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclosporine a on single-dose pharmacokinetics of intravenous itraconazole in patients with hematologic malignancies.
Timmers GJ; Kessels LW; Wilhelm AJ; Veldkamp AI; Bosch TM; Beijnen JH; Huijgens PC
Ther Drug Monit; 2008 Jun; 30(3):301-5. PubMed ID: 18520601
[TBL] [Abstract][Full Text] [Related]
14. Quantitative prediction of metabolic inhibition of midazolam by itraconazole and ketoconazole in rats: implication of concentrative uptake of inhibitors into liver.
Yamano K; Yamamoto K; Kotaki H; Sawada Y; Iga T
Drug Metab Dispos; 1999 Mar; 27(3):395-402. PubMed ID: 10064572
[TBL] [Abstract][Full Text] [Related]
15. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat.
Rabinow B; Kipp J; Papadopoulos P; Wong J; Glosson J; Gass J; Sun CS; Wielgos T; White R; Cook C; Barker K; Wood K
Int J Pharm; 2007 Jul; 339(1-2):251-60. PubMed ID: 17398045
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble self-emulsifying system and in solid dispersion.
Park MJ; Ren S; Lee BJ
Biopharm Drug Dispos; 2007 May; 28(4):199-207. PubMed ID: 17377960
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of caffeic acid phenethyl ester and its catechol-ring fluorinated derivative following intravenous administration to rats.
Wang X; Pang J; Maffucci JA; Pade DS; Newman RA; Kerwin SM; Bowman PD; Stavchansky S
Biopharm Drug Dispos; 2009 Jul; 30(5):221-8. PubMed ID: 19544289
[TBL] [Abstract][Full Text] [Related]
18. Plasma pharmacokinetics and tissue distribution of [6]-gingerol in rats.
Jiang SZ; Wang NS; Mi SQ
Biopharm Drug Dispos; 2008 Dec; 29(9):529-37. PubMed ID: 19051331
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.
Boogaerts MA; Maertens J; Van Der Geest R; Bosly A; Michaux JM; Van Hoof A; Cleeren M; Wostenborghs R; De Beule K
Antimicrob Agents Chemother; 2001 Mar; 45(3):981-5. PubMed ID: 11181397
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of itraconazole in diabetic rats.
Lee U; Choi YH; Kim SH; Lee BK
Antimicrob Agents Chemother; 2010 Feb; 54(2):931-3. PubMed ID: 19995926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
